Economic Observation Network Dongyangguang Pharmaceutical (06887. HK) has sufficient production capacity to quickly respond to the demand for medication during the flu season, and its Olagliflozin capsules have been included in the 2026 version of the national medical insurance catalog.
Business Progress
The positive rate of influenza virus in the 46th week of China CDC (11-09 to 11-15) was 22.5%, rising for four consecutive weeks, and the country has entered a moderate epidemic level; Dingdang Quick Medicine Platform Oseltamivir Week on Week Sales+77%
Progress of medical insurance directory
On November 15th, it was announced that Olagliflozin capsules would be included in the 2026 version of the national medical insurance catalog
The above content is based on publicly available information and does not constitute investment advice.